Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Radiation Exposure in Chronic Total Occlusion Procedures Reduced by 52% Over a Decade
Added: 3 months ago Source:  Radcliffe Cardiology
AUTHOR: David RamseyA multicenter registry study from the European CTO Club has revealed a remarkable 52% reduction (p<0.001) in radiation exposure for percutaneous coronary interventions (PCI) in chronic total occlusion (CTO) cases over 12 years. Despite increasing lesion complexity, improved procedural success and modernization of radiation management strategies have significantly lowered… View more

Intervention
Author(s): Abay Bakytzhanuly , Tolegen Otegen , Omirbek Nuralinov Added: 8 months ago

Electrophysiology & Arrhythmia
Outcomes of CTO PCI in a Non-surgical Centre
Author(s): Thomas R Gilpin , Annette Maznyczka , Brijesh Anantharam , et al Added: 1 year ago

Intervention

Prevention & Chronic Conditions
Occlutech PFO Closure Device: A Long-Term Review
Author(s): Daniela Trabattoni Added: 1 year ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only… View more

Intervention
Author(s): Yosef Manla Added: 11 months ago
Interventional Cardiology 2024;19:e24. View more

Intervention
Author(s): Yosef Manla Added: 11 months ago
Interventional Cardiology 2024;19:e24. View more

Intervention
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial
Author(s): Michael J Reardon Added: 1 year ago
TCT 23 - In this succinct interview, we are joined by Dr Michael Reardon (Houston Methodist, US) to discuss the four-year outcomes from the EVOLUT Low-Risk Trial (NCT03635424), sponsored by Medtronic. The EVOLUT Low-risk trial is a multicenter, prospective, single-arm study which aimed to assess the procedural safety and efficacy of the Medtronic TAVR system in 150 patients with bicuspid… View more

Intervention
Robotic PCI
Author(s): Arif A Khokhar , Andrea Marrone , Konstantinos Bermpeis , et al Added: 1 year ago

Digital Health

Intervention
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 3 weeks ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention
Predilation in pPCI
Author(s): Mahmoud Tantawy , Marwan Saad , Sherif Hussien , et al Added: 1 month ago

Intervention

MI/ACS